Back to Search Start Over

AbbVie submits SKYRIZI approval applications to US FDA and European Medicines Agency

Source :
M2 EquityBites (EQB). April 8, 2021
Publication Year :
2021

Abstract

M2 EQUITYBITES-April 8, 2021-AbbVie submits SKYRIZI approval applications to US FDA and European Medicines Agency (C)2021 M2 COMMUNICATIONS http://www.m2.com United States-based AbbVie (NYSE: ABBV) announced on Wednesday that it has [...]

Subjects

Subjects :
United States. Food and Drug Administration -- Technology application
Psoriasis -- Drug therapy
Antiarthritic agents -- Technology application
Drug approval -- Technology application
Technology application
Business

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 EquityBites (EQB)
Publication Type :
News
Accession number :
edsgcl.657730288

Tools

Authors Abstract Subjects Details